SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 26 filers reported holding SALARIUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $450,000 | -28.5% | 424,800 | 0.0% | 0.17% | -45.2% |
Q1 2021 | $629,000 | +91.8% | 424,800 | +17.8% | 0.30% | +17.3% |
Q4 2020 | $328,000 | +50.5% | 360,556 | +39.6% | 0.26% | +45.3% |
Q3 2020 | $218,000 | -36.1% | 258,249 | 0.0% | 0.18% | +7.2% |
Q2 2020 | $341,000 | +63.9% | 258,249 | -15.1% | 0.17% | +30.5% |
Q1 2020 | $208,000 | – | 304,347 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 1,354,291 | $1,381,000 | 0.44% |
X-Square Capital, LLC | 100,658 | $103,000 | 0.05% |
Maven Securities LTD | 1,212,575 | $1,237,000 | 0.04% |
Kepos Capital LP | 548,054 | $559,000 | 0.04% |
1900 WEALTH MANAGEMENT LLC | 40,000 | $41,000 | 0.00% |
Laird Norton Wetherby Wealth Management, LLC | 39,746 | $41,000 | 0.00% |
Virtu Financial LLC | 29,708 | $30,000 | 0.00% |
Financial Advocates Investment Management | 11,472 | $12,000 | 0.00% |
MEITAV INVESTMENT HOUSE LTD | 52,000 | $53,000 | 0.00% |
NORTHERN TRUST CORP | 67,227 | $68,000 | 0.00% |